The breast biopsy market was estimated at US$ 783 million in 2021 and is expected to grow at a CAGR of 10.86% during 2022-2028 to reach US$ ~1.28 billion in 2028.
North America dominates the Breast Biopsy Market, driven by advanced medical infrastructure, early detection awareness, and minimally invasive procedures.